Press "Enter" to skip to content

Merck’s Keytruda wins US approval for wider lung cancer population; CymaBay breaks out positive data from ongoing PBC study – Endpoints News

admin 0

Merck’s Keytruda wins US approval for wider lung cancer population; CymaBay breaks out positive data from ongoing PBC study  Endpoints News

… → Days after Merck’s entrenched flagship Keytruda immunotherapy scored a key lung cancer approval in China, the drugmaker has expanded its lung cancer …

“lung cancer” – Google News

(Visited 2 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *